Abstract on the first 8 years of The Global Programme to Eliminate Lymphatic Filariasis. Hooper et al, Annals of Tropical Medicine & Parasitology, Volume 103, 2009 – Issue sup1.
This review examines the thinking and the processes behind the development of albendazole, from the first ideas in the mid 1980s to the establishment of the Global Programme to Eliminate Lymphatic Filariasis.
Abstract on progress made in preventing the disability of lymphatic filariasis, the monitoring and evaluation of such disability and its control, and the integration of disability prevention with mass drug administrations and efforts to control other disabling diseases.
Abstract addressing the central role that filariasis patients have played in the Tanzania Lymphatic Filariasis Elimination Programme to date, and covering some of the clinical successes achieved between 1999 and 2009.
Abstract on the integration of mass drug administrations against multiple NTDs. Hopkins, Annals of Tropical Medicine & Parasitology, Volume 103, 2009 – Issue sup1.
Article on a symposium held to commemorate the 10th anniversary of the donation of Mectizan® and albendazole for the elimination of lymphatic filariasis.
Abstract on the partnership launched in 1999 between the World Health Organization’s Programme for the Prevention of Blindness and Deafness and the International Agency for the Prevention of Blindness for onchocerciasis control.
Abstract on the role of the World Bank in supporting the global partnership dedicated to the control of onchocerciasis. Bangoura, Annals of Tropical Medicine and Parasitology, 2008 Sep; 102 Suppl 1:31-3.
Abstract on the Onchocerciasis Elimination Program for the Americas (OEPA). Sauerbrey, Annals of Tropical Medicine and Parasitology, 2008 Sep; 102 Suppl 1:25-9.
Abstract on the establishment of the Onchocerciasis Control Programme in West Africa. Boatin, Annals of Tropical Medicine and Parasitology, 2008 Sep; 102 Suppl 1: 13-7.
Abstract on the involvement of the NGDO network in onchocerciasis control. Haddad, Annals of Tropical Medicine and Parasitology, 2008 Sep; 102 Suppl 1:35-8.
Abstract on the Mectizan® Donation Program (MDP), which was launched in 1987 by Merck & Co., Inc., Kenilworth, N.J., U.S.A.* Thylefors, Annals of Tropical Medicine and Parasitology, 2008 Sep; 102 Suppl 1:39-44.
Abstract on The African Programme for Onchocerciasis Control (APOC), which was launched in 1995 for the ultimate purpose of eliminating human onchocerciasis from the African countries in which the disease was endemic.
Abstract on The Special Intervention Zones (SIZ) of the former Onchocerciasis Control Programme (OCP), which were launched in December 2002, following the closure of the OCP, to sustain the momentum that had been gained for onchocerciasis control through Mectizan distribution and vector control.
Collection of scientific articles on two decades of the use of Mectizan® in the effort to control (and eventually eliminate as a public health problem) the parasitic disease of onchocerciasis.